Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis by Gerds, AT, Savona, MR, Scott, BL, Talpaz, M, Egyed, M, Harrison, CN, Yacoub, A, Vannucchi, A, Mead, AJ, Kiladjian, J-J, O'Sullivan, J, García-Gutiérrez, V, Bose, P, Rampal, RK, Miller, CB, Palmer, J, Oh, ST, Buckley, SA, Mould, DR, Ito, K, Tyavanagimatt, S, Smith, JA, Roman-Torres, K, Devineni, S, Craig, AR, Mascarenhas, JO

“…American Society of Hematology…”

CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies by Bueno, C, Barrena, S, Bataller, A, Ortiz-Maldonado, V, Elliott, N, O'Byrne, S, Wang, G, Rovira, M, Gutierrez-Agüera, F, Trincado, JL, Gonzalez, M, Morgades, M, Sorigué, M, Barcena, P, Zanetti, SR, Torrebadell, M, Vega-García, N, Rives, S, Mallo, M, Sole, F, Mead, AJ, Roberts, I, Thongjuea, S, Psaila, B, Juan, M, Delgado, J, Urbano-Ispizua, Á, Ribera, J-M, Orfao, A, Roy, A, Menéndez, P

“…American Society of Hematology…”

Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice by Lysenko, V, Wildner-Verhey van Wijk, N, Zimmermann, K, Weller, M-C, Bühler, M, Wildschut, MHE, Schürch, P, Fritz, C, Wagner, U, Calabresi, L, Psaila, B, Flavell, RA, Vannucchi, AM, Mead, AJ, Wild, PJ, Dirnhofer, S, Manz, MG, Theocharides, APA

“…American Society of Hematology…”

Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients by Sirinukunwattana, K, Aberdeen, A, Theissen, H, Sousos, N, Psaila, B, Mead, AJ, Turner, GDH, Rees, G, Rittscher, J, Royston, D

“…American Society of Hematology…”

Single-cell methods in myeloproliferative neoplasms: old questions, new technologies by O'Sullivan, JM, Mead, AJ, Psaila, B

“…American Society of Hematology…”

CNL and aCML should be considered as single entity based on molecular profiles and outcomes by Carreño-Tarragona, G, Alvarez-Larran, A, Harrison, CN, Martínez-Ávila, JC, Hernandez-Boluda, JC, Ferrer-Marin, F, Radia, DH, Mora Casterá, E, Francis, S, González-Martínez, T, Goddard, K, Perez-Encinas, M, Narayanan, S, Raya, JM, Singh, V, Toth, P, Gutiérrez, X, Amat Martinez, P, McIlwaine, L, Alobaidi, M, Mayani, K, McGregor, A, Stuckey, R, Psaila, B, Segura, A, Alvares, CL, Davidson, K, Osorio, S, Cutting, R, Sweeney, CP, Rufian, L, Moreno, L, Cuenca, I, Smith, J, Morales, ML, Gil-Manso, R, Koutsavlis, I, Wang, L, Mead, AJ, Rozman, M, Martínez-López, J, Ayala, R, Cross, NC

“…American Society of Hematology…”

Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells by Matsuoka, S, Facchini, R, Luis, TC, Carrelha, J, Woll, PS, Mizukami, T, Wu, B, Boukarabila, H, Buono, M, Norfo, R, Arai, F, Suda, T, Mead, AJ, Nerlov, C, Jacobsen, SEW

“…American Society of Hematology…”

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib by O'Sullivan, JM, Hamblin, A, Yap, C, Fox, S, Boucher, R, Panchal A, Alimam, S, Dreau, H, Howard, K, Ware, P, Cross, NCP, McMullin, MF, Harrison, CN, Mead, AJ

“…American Society of Hematology…”